Cindy L. Citrone
Showing 1–3 of 3 transcripts.
- Milken Institute1h 0m
The Power of Place-Based Philanthropy
Diana Bucco, Cindy L. Citrone, Shirley Franklin, Wes Moore, La June Montgomery Tabron
Five institutional and personal philanthropy leaders, including Diana Bucco, Lejeune Callison-Montgomery-Tabron, Wes Moore, Shirley Franklin, and Cindy Citrone, convened to define place-based strategies that anchor resources within specific geographies to address systemic issues like poverty and racism. The panel highlighted measurable outcomes such as reducing veterans homelessness in New York to near zero and transforming a lowest-performing Atlanta school into a top-five district institution through holistic, long-term community investment. By prioritizing local governance, generational commitments, and the "Series A" role of de-risking innovations for eventual government adoption, these leaders aim to shift philanthropy from reactive grant-making to sustainable, neighborhood-scale transformation.
- Milken Institute1h 1m
Mental Health and the Next Generation
Lynn Goldman, Cindy L. Citrone, Oren Frank, Elana Jacobs, Alison Malmon
Hosted by Lynn Goldman, this panel convened leaders from the 33 Foundation, Talkspace, Crisis Text Line, and Active Minds to address a US mental health crisis marked by severe provider shortages and systemic treatment gaps. The session detailed innovative solutions ranging from digital therapy platforms serving over one million users and AI-driven crisis triage to peer-led campus networks, while identifying regulatory hurdles in licensing and emergency service classification that impede scalability. Participants concluded with a unified call to action for integrated data research, updated health education curricula, and policy reforms to achieve parity between mental and physical healthcare.
- Milken Institute1h 1m
Supercharge the Search for Cures: Medical Philanthropists Reinvent Giving to Get Results
LaTese Briggs, Debra Black, Cindy L. Citrone, Joyce Keller, Melissa Stevens, Rob Citron
A panel of leaders from the Melanoma Research Alliance, 33 Foundation, and Gilbert Family Foundation discussed a strategic sector shift from reactive check-writing to active venture philanthropy that leverages flexible capital to fill the translational research gap. These institutions demonstrated high-impact outcomes, such as funding all 11 FDA-approved melanoma therapies and developing a non-profit venture fund to accelerate breast cancer treatments, while also employing non-cash assets like sports partnerships to drive systemic organ donation reforms. By addressing structural barriers including the nonprofit consolidation of small entities and the medical device "valley of death," the experts advocated for patient-centric infrastructure investments and deep, data-driven engagement models to maximize scientific returns.